Allergy

Blepharitis

COVID-19

Cataract

Comanagement

Comprehensive Eye Exams

Conjunctivitis

Contact Lenses

Cornea

Diabetic Eye Disease

Dry Eye

Geographic Atrophy

Glasses

Glaucoma

LASIK

Lens Technology

Lid and Lash

Myopia

Nutrition

Ocular Surface Disease

Optic Relief

Patient Care

Pediatrics

Presbyopia

Ptosis

Refractive Surgery

Retina

Technology

Therapeutic Cataract & Refractive

News

All News

Practice Management

Media

All Videos

Expert Interviews

Podcasts

Medical World News

Viewpoints

Insights

Case Based Roundtable Series

Case Studies

Case of the Quarter

Practice Ownership

Rapid Readout

What’s Your WhEYE?

Conferences

Conference Coverage

Conference Listing

Conference Recaps

Blog

Publications

Digital Edition

Supplements And Featured Publications

iTech

Partners

Resources

Job Board

Subscribe

Articles

Xiidra is a prescription eye drop used to treat the signs and symptoms of dry eye disease (DED) and works by targeting the source of inflammation.

New study demonstrates Xiidra's efficacy in alleviating discomfort in symptomatic contact lens wearers

The trial will evaluate the solution in treating significant, chronic night driving impairment in keratorefractive patients with reduced mesopic vision.

Opus Genetics doses first patient in phase 3 LYNX-3 trial evaluating phentolamine ophthalmic solution 0.75%

The lens portfolio includes spherical, aspheric, toric, multifocal, multifocal toric, reverse geometry, and keratoconic contact lenses.

Bausch + Lomb launches ASANA gas permeable lenses in the US

From discussion to decision: Educating patients on IOL expectations for better outcomes

Optometry Times delivers clinical news, practice insights, and research updates by optometrists for optometrists to advance care and patient outcomes.

Advertise

About Us

Editorial

Contact Us

Terms & Conditions

Privacy

Do not sell my Information

Optometry Times – Clinical News & Expert Optometrist Insights

Facebook

Instagram

LinkedIn

Spotlight

Clinical

Myopia- Management

Optometry Times® delivers easily digested, practical information by ODs for ODs that can be immediately applied to improve the clinical experience as well as practice performance. OD provides data, analysis, tools and resources through multichannel touchpoints.

Test

Is your organization missing from this list? Reach out to Noelle Stango and Marissa Fiorentino to learn more about the complimentary strategic partnership program: nstango@mjhlifesciences.com and mfiorentino@mjhlifesciences.com

1rem

Strategic Alliance Partners

Due to ubiquity, optometrists tend to undertreat patients with dry eye.

Embracing dry eye

The optometrist’s role in managing age-related macular degeneration with OCT-A

What we know and what we do not know…yet.

Semifluorinated alkanes in dry eye disease

We believe Eyes Matter, Eyecare Matters and that Independent Optometry is the highest form of Eyecare.

Keplr Vision

Keplr Vision | Strategic Alliance Partners

Latest from Keplr Vision